Guidelines for the diagnosis and treatment of depressive disorders by integrating Chinese and Western medicine (English edition)
Year: 2025
Type: article
Abstract: Depressive disorders are mental illnesses that seriously affect public health. There are approximately 320 million patients with depression worldwide, accounting for 4.4% of the total disease burden. 1 Depression leads to social and occupational impairment, diminished quality of life and an elevated risk of death by suicide. The Global Burden of Disease 2019 study indicated that depression is the second leading medical cause of disability worldwide.2 Despite advances in treatment, several challenges remain in the clinical management of depression, particularly the relatively low response rates among older adults and younger individuals.3 The delayed efficacy of commonly prescribed antidepressants (ADs) poses a risk of inadequate control over suicidal tendencies. Moreover, the numerous adverse reactions associated with ADs, particularly during the initial stages of treatment, significantly impact patient adherence.4
Source: General Psychiatry
Institutions: Shanghai Jiao Tong University, Shanghai Mental Health Center, Guangzhou University of Chinese Medicine, Shenzhen Traditional Chinese Medicine Hospital, Guangdong Provincial Hospital of Chinese Medicine, Tongde Hospital of Zhejiang Province, Shandong University of Traditional Chinese Medicine, Changchun University of Chinese Medicine, The Affiliated Hospital to Changchun University of Chinese Medicine, Guangzhou Medical University, Capital Medical University, Beijing Anding Hospital, University of Hong Kong, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Sir Run Run Shaw Hospital, Zhejiang University
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4407318781